Anti-Pseudomonas Aeruginosa IgY Antibodies Induce Specific Bacterial Aggregation and Internalization in Human Polymorphonuclear Neutrophils
Overview
Affiliations
Polymorphonuclear neutrophils (PMNs) are essential cellular constituents in the innate host response, and their recruitment to the lungs and subsequent ubiquitous phagocytosis controls primary respiratory infection. Cystic fibrosis pulmonary disease is characterized by progressive pulmonary decline governed by a persistent, exaggerated inflammatory response dominated by PMNs. The principal contributor is chronic Pseudomonas aeruginosa biofilm infection, which attracts and activates PMNs and thereby is responsible for the continuing inflammation. Strategies to prevent initial airway colonization with P. aeruginosa by augmenting the phagocytic competence of PMNs may postpone the deteriorating chronic biofilm infection. Anti-P. aeruginosa IgY antibodies significantly increase the PMN-mediated respiratory burst and subsequent bacterial killing of P. aeruginosa in vitro. The mode of action is attributed to IgY-facilitated formation of immobilized bacteria in aggregates, as visualized by fluorescence microscopy and the induction of increased bacterial hydrophobicity. Thus, the present study demonstrates that avian egg yolk immunoglobulins (IgY) targeting P. aeruginosa modify bacterial fitness, which enhances bacterial killing by PMN-mediated phagocytosis and thereby may facilitate a rapid bacterial clearance in airways of people with cystic fibrosis.
Ahmadi T, Behrouz B, Mousavi Gargari S Sci Rep. 2024; 14(1):405.
PMID: 38172232 PMC: 10764880. DOI: 10.1038/s41598-023-50859-x.
IgY antibodies: The promising potential to overcome antibiotic resistance.
El-Kafrawy S, Abbas A, Oelkrug C, Tahoon M, Ezzat S, Zumla A Front Immunol. 2023; 14:1065353.
PMID: 36742328 PMC: 9896010. DOI: 10.3389/fimmu.2023.1065353.
Chicken IgY reduces the risk of urinary tract infections in a murine model.
Schwartz F, Christophersen L, Thomsen K, Baekdal S, Bendixen M, Jorgensen M Front Microbiol. 2022; 13:988386.
PMID: 36160201 PMC: 9505517. DOI: 10.3389/fmicb.2022.988386.
Immune Response to Biofilm Growing Pulmonary Infection.
Thomsen K, Hoiby N, Jensen P, Ciofu O, Moser C Biomedicines. 2022; 10(9).
PMID: 36140163 PMC: 9495460. DOI: 10.3390/biomedicines10092064.
Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases.
Lee L, Samardzic K, Wallach M, Frumkin L, Mochly-Rosen D Front Immunol. 2021; 12:696003.
PMID: 34177963 PMC: 8220206. DOI: 10.3389/fimmu.2021.696003.